【摘要】：Th22是近幾年新發(fā)現(xiàn)的一種輔助型T細胞亞群。Th22細胞及其主要的細胞因子白細胞介素22(IL-22)被證實在各種自身免疫疾病及慢性炎性疾病如類風濕性關(guān)節(jié)炎、銀屑病、慢性異位性皮炎、哮喘、系統(tǒng)性硬化癥等患者中均表達異常。然而關(guān)于Th22細胞及IL-22在冠心病中的作用及發(fā)病機制尚未明確。如能明確Th22及IL-22作用于冠心病的作用機制,可作為防治冠心病的新思路和新靶點。本文就Th22及其主要細胞因子IL-22的最新研究進展及臨床應用現(xiàn)狀做一全面綜述。
[Abstract]:Th22 is a newly discovered helper T cell subgroup Th.22 cells and its main cytokine IL-22 (IL-22) has been confirmed in various autoimmune diseases and chronic inflammatory diseases such as rheumatoid arthritis and psoriasis. Abnormal expression was found in patients with chronic atopic dermatitis, asthma, systemic sclerosis and so on. However, the role and pathogenesis of Th22 cells and IL-22 in coronary heart disease are not clear. If we can clarify the mechanism of Th22 and IL-22 acting on coronary heart disease, it can be used as a new idea and target for prevention and treatment of coronary heart disease. In this paper, the latest research progress and clinical application of Th22 and its main cytokine IL-22 are reviewed.
【作者單位】： 長江大學第二臨床醫(yī)學院;
【分類號】：R541.4

【相似文獻】

相關(guān)期刊論文 前2條

1 陳榮華;;Th22細胞及其細胞因子在急性淋巴細胞白血病表達水平及其意義分析[J];中國實驗血液學雜志;2013年04期

2 劉立民;張興霞;趙廣圣;司葉俊;林國強;張彥明;何廣勝;吳德沛;;原發(fā)免疫性血小板減少癥患者外周血Th22細胞水平的變化及意義[J];細胞與分子免疫學雜志;2012年12期

，

本文編號：2482803